American Century Companies’s PDL BioPharma, Inc. PDLI Stock Holding History

American Century Companies’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-152,745	Closed	-$1.14M	–	1550
2014 Q3	$1.14M	Sell	152,745 -497,038	-76%	-$4.61M	﹤0.01%	1155
2014 Q2	$6.29M	Sell	649,783 -82,744	-11%	-$737K	0.01%	822
2014 Q1	$6.09M	Buy	732,527 +10,652	+1%	+$91.3K	0.01%	851
2013 Q4	$6.09M	Buy	721,875 +11,479	+2%	+$96.7K	0.01%	849
2013 Q3	$5.66M	Buy	710,396 +334,286	+89%	+$2.69M	0.01%	852
2013 Q2	$2.9M	Buy	+376,110	New	+$2.93M	﹤0.01%	994

Other funds holding PDLI

ACM

Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American Century Companies's PDLI Position: Q4 2014 in Review

American Century Companies sold out of PDL BioPharma, Inc. (PDLI) in Q4 2014, closing a stake of 152,745 shares — an estimated $1.14M sold.

American Century Companies first reported a position in PDLI in Q2 2013 and held it in 6 quarters. The position peaked at $6.29M in Q2 2014. 223 funds tracked by Wall St. Rank hold PDLI as of Q4 2014.

American Century Companies reported no remaining PDL BioPharma, Inc. position as of Q4 2014 after selling out during the quarter.
American Century Companies sold 152,745 PDL BioPharma, Inc. shares in Q4 2014, an estimated $1.14M.
American Century Companies first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 6 quarters.
American Century Companies's PDL BioPharma, Inc. position peaked at $6.29M in Q2 2014.
223 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2014.

Based on American Century Companies's 13F filing for Q4 2014, filed 27 Jan 2015.